Clinical Trial

Safety and Efficacy of GL-2045 in Patients With Immune Thrombocytopenia

Name: Safety and Efficacy of GL-2045 in Patients With Immune Thrombocytopenia — clinical trial record (NCT07605845)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The goal of this clinical trial is to demonstrate GL-2045 safety and efficacy proof of concept by demonstrating intravenous immunoglobulin (IVig)-like platelet responses in adult patients with Immune Thrombocytopenia (ITP).

Trial Details

NCT Number	NCT07605845
Lead Sponsor	Gliknik Inc.
Conditions	Immune Thrombocytopenia
Enrollment	42 participants
Start Date	2026-04-14
Primary Completion	2027-12-06 (estimated)
Study Completion	2027-12-06 (estimated)
Updated on ClinicalTrials.gov	2026-05-26